You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

CLDN6 positive

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor Trial in Chuo Ku (SAIL66, Tocilizumab)

Not yet recruiting
  • Solid Tumor
  • Chuo Ku, Tokyo, Japan
    National Cancer Center Hospital
Feb 9, 2023

Stage IV Ovarian Cancer, Testis Cancer, Refractory, Endometrial Cancer Recurrent Trial in Guangzhou (Claudin6 targeting CAR-NK

Recruiting
  • Stage IV Ovarian Cancer
  • +3 more
  • Claudin6 targeting CAR-NK cells
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Jun 5, 2022

Solid Tumor Trial in Singapore, Spain, United States (BNT142)

Recruiting
  • Solid Tumor
  • BNT142
  • Los Angeles, California
  • +9 more
Jul 21, 2022

Advanced Solid Tumor Trial in Chengdu (Dual-targeting CLDN18.2 and PD-L1 CAR-T cells)

Not yet recruiting
  • Advanced Solid Tumor
  • Dual-targeting CLDN18.2 and PD-L1 CAR-T cells
  • Chengdu, Sichuan, China
    West China Hospital, Sichuan University
Oct 9, 2023

Gastric Cancer, Pancreatic Cancer Trial (LM302+Toripalimab)

Not yet recruiting
  • Gastric Cancer
  • Pancreatic Cancer
  • (no location specified)
Jun 28, 2023

Locally Advanced Unresectable or Metastatic Solid Tumors Trial in China (SG1906)

Recruiting
  • Locally Advanced Unresectable or Metastatic Solid Tumors
  • Beijing, Beijing, China
  • +8 more
May 12, 2023

Gastric Cancer, Pancreatic Cancer, Advanced Ovarian Carcinoma Trial (Claudin 18.2 CAR-T)

Not yet recruiting
  • Gastric Cancer
  • +3 more
  • Claudin 18.2 CAR-T
  • (no location specified)
Jul 21, 2022

Advanced Solid Tumor Trial in Shanghai (IMC008)

Recruiting
  • Advanced Solid Tumor
  • Shanghai, Shanghai, China
    Shanghai Changhai Hospital
Apr 19, 2023

Solid Tumor Trial in Beijing (QLS31905, Nab paclitaxel, Gemcitabine)

Not yet recruiting
  • Solid Tumor
  • Beijing, Beijing, China
    Beijing Cancer Hospital
Sep 10, 2023

Metastatic Solid Tumor Trial (TAC01-CLDN18.2)

Not yet recruiting
  • Metastatic Solid Tumor
  • TAC01-CLDN18.2
  • (no location specified)
May 8, 2023

Solid Tumor, Gastric Cancer, Pancreatic Adenocarcinoma Trial in China (AB011 Injection)

Recruiting
  • Solid Tumor
  • +2 more
  • AB011 Injection
  • Hefei, Anhui, China
  • +11 more
Feb 7, 2022

Advanced Solid Tumors Trial in United States (Drug:LM-102)

Terminated
  • Advanced Solid Tumors
  • California City, California
  • +5 more
Oct 24, 2022

Solid Tumor, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma Trial in Canada, Spain, United States (BNT141,

Recruiting
  • Solid Tumor
  • +7 more
  • BNT141
  • +2 more
  • Duarte, California
  • +10 more
Aug 23, 2022

Biliary Tract Tumors Trial (TST001)

Not yet recruiting
  • Biliary Tract Neoplasms
  • (no location specified)
Dec 28, 2021

Non-squamous NSCLC, Epithelial Ovarian Cancer Trial (AMG 794)

Not yet recruiting
  • Non-squamous Non-small Cell Lung Cancer
  • Epithelial Ovarian Cancer
  • AMG 794
  • Orange, California
    University of California at Irvine
Jan 25, 2023

Advanced Solid Tumor Trial in Shanghai (LM-302 Injection)

Recruiting
  • Advanced Solid Tumor
  • LM-302 Injection
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Dec 29, 2021

Solid Tumor, Adult Trial in Wuxi (89Zr-NY005)

Not yet recruiting
  • Solid Tumor, Adult
  • Wuxi, Jiangsu, China
    Wuxi No. 4 People's Hospital
Jul 23, 2021

Advanced Cancer, Metastatic Cancer, Ovarian Cancer Trial in Sarasota, Nashville (DS-9606a)

Recruiting
  • Advanced Cancer
  • +3 more
  • Denver, Colorado
  • +6 more
Jan 12, 2023

Incurable Platinum Refractory Germ Cell Tumors, Tumors Trial in Indianapolis, New York, Philadelphia (ASP1650)

Completed
Has Results
  • Incurable Platinum Refractory Germ Cell Tumors
  • Tumors
  • Indianapolis, Indiana
  • +2 more
Nov 30, 2021

Solid Tumor Trial in Suzhou (IBI345)

Recruiting
  • Solid Tumor
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jan 6, 2022

Advanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment Failed Trial in Hangzhou (dalpiciclib;

Recruiting
  • Advanced HR-positive and HER2-negative Breast Cancer; CDK4/6 Inhibitor Treatment Failed
  • dalpiciclib; fluvestrant; compound gossypol acetate tablets
  • Hangzhou, Zhejiang, China
    zhejiangCH
Nov 9, 2023

Breast Tumor Female Trial in Beijing (CDK4/6 inhibitor (Qilu),Trastuzumab (Hanquyou))

Recruiting
  • Breast Neoplasm Female
  • CDK4/6 inhibitor (Qilu),Trastuzumab (Hanquyou)
  • Beijing, Beijing, China
  • +1 more
Jul 31, 2023

CDK4/6 Inhibitors in Hormone Receptor-positive Advanced Breast

Not yet recruiting
  • Breast Cancer
  • CDK4/6 inhibitor
  • Shanghai, Shanghai, China
    Renji Hospital, School of Medicine, Shanghai Jiao Tong Universit
Apr 5, 2023

Pancreatic Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in Worldwide (zolbetuximab,

Recruiting
  • Pancreatic Cancer
  • +2 more
  • Goodyear, Arizona
  • +131 more
Jan 30, 2023

Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Trial (Giredestrant, Fulvestrant, Abemaciclib)

Not yet recruiting
  • Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
  • (no location specified)
Sep 26, 2023